Opens in a new tab

Breaking news

Isomorphic Labs Raises $5 Billion To Advance AI-Designed Medicines

Isomorphic Labs, the AI drug discovery company founded by Demis Hassabis, has raised $5 billion in a Series C funding round, highlighting growing investor confidence in artificial intelligence’s potential to transform pharmaceutical research.

The round was co-led by Greenoaks and Sequoia Capital, with participation from Andreessen Horowitz and Alphabet, Google’s parent company. Isomorphic said the funding will support the design and development of new medicines using AI.

Hassabis Focuses On The Next Phase Of Isomorphic Labs

The fundraising comes three and a half months after Hassabis stepped back as CEO of Google DeepMind, the AI research lab he co-founded before its acquisition by Google in 2014. He has led Isomorphic Labs since it spun out of DeepMind in 2021.

“When we founded Isomorphic, our conviction was that biology could be understood and modelled at the most fundamental molecular level and radically accelerated through AI,” Hassabis said.

He added that the new capital would help the company develop foundational biology models, deepen its understanding of systemic disease and advance its first therapeutic programmes towards clinical trials.

AI Drug Discovery Attracts Growing Investment

Isomorphic is developing a proprietary drug-design engine alongside a pipeline of potential therapies designed using AI. The company aims to apply these tools to the development of a new generation of medicines.

It is entering a market that is attracting increasing attention from technology companies and investors. Anthropic announced an AI drug discovery programme in June, while OpenAI partnered with Novo Nordisk in April to explore the technology’s applications in drug development.

Drug discovery startups raised a record $23.2 billion in 2026, according to deal-tracking platform Dealroom.

Isomorphic’s latest funding follows a $2.1 billion Series B round announced in May, bringing the company’s fundraising into focus as investment in AI-driven pharmaceutical research continues to grow.

Greek Investment In Cyprus Rises To €9.2 Billion As Both Countries Seek Closer Business Ties

Greek direct investment in Cyprus reached €9.2 billion in June 2026, up nearly two-thirds from €5.6 billion in 2024, as business leaders in both countries seek closer cooperation to expand into international markets.

Invest Cyprus chairman Evgenios Evgeniou announced the figures on Wednesday, adding that Cypriot investment in Greece stood at around €2.7 billion. More than 1,500 businesses with Greek interests operate in Cyprus, while bilateral trade in goods totalled €3.3 billion in 2025. Exports of Cypriot-produced goods to Greece rose by 12%.

Cyprus And Greece Develop Joint Investment Plans

Evgeniou said the countries could combine their business networks to attract international investment. Cyprus has strong links across the Middle East and eastern Mediterranean, while Greece has an established presence in the Balkans and southeastern Europe.

In April, Invest Cyprus and Enterprise Greece renewed their cooperation agreement, paving the way for joint investment initiatives, business delegations and exchanges of expertise. Following a recent meeting with Greece’s deputy foreign minister and Enterprise Greece’s chairman, the parties agreed to develop the memorandum into an action plan with specific initiatives and targets.

The first closed-door meeting with Greek businesses operating in Cyprus is scheduled for early December, with representatives of both governments expected to attend.

Energy And Technology Among Priority Sectors

Energy, defence manufacturing and defence technology are among the sectors identified for closer cooperation. Evgeniou cited the proposed Cyprus-Greece electricity interconnector as an example of the coordination required for major cross-border projects.

Vicky Makrygianni, director of international relations at the Hellenic Federation of Enterprises, said EU trade agreements with Mercosur, India, Canada and Japan could open opportunities that individual companies might struggle to pursue alone. She highlighted potential in energy, agri-food, construction, technology, artificial intelligence and cybersecurity.

Andreas Demetriades, vice-president for the economy at the Cyprus Chamber of Commerce and Industry, said Greece could contribute its industrial base and access to European and Balkan markets, while Cyprus offers financial and professional services, shipping expertise and links to the Middle East and Gulf.

“Together we can create a strong business network that connects three continents,” he said, calling for more joint ventures and closer cooperation between chambers of commerce, including the sharing of investment opportunities.

Makrygianni also noted that Greece could draw on Cyprus’ experience in competitiveness, regulatory simplification and energy security when it assumes the presidency of the Council of the European Union in the second half of 2027.

Nicosia Seeks Tourism And Urban Development Investment

Nicosia mayor Charalambos Prountzos outlined further investment opportunities in the capital. The city aims to increase its share of Cyprus’ tourist arrivals from 5.7% to 10% and raise annual tourism revenue from around €170 million to €400 million by 2029.

Hotel investments exceeding €250 million are expected to double the city’s tourist bed capacity by 2027, with additional projects planned for the historic centre.

Plans also include the redevelopment of 1.4 million square metres in the Sopaz area of eastern Nicosia for businesses, housing and research facilities. Prountzos described the project as “a new city within the city of Nicosia”.

The municipality is working with the government and is open to partnerships with Greek businesses and research organisations, aiming to attract investment while benefiting surrounding neighbourhoods.

Aretilaw firm
Uol
eCredo
The Future Forbes Realty Global Properties

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter